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Abstract In this part of a series on founder mutations in
the Netherlands, we review familial idiopathic ventricular
fibrillation linked to the DPP6 gene. Familial idiopathic
ventricular fibrillation determines an intriguing subset of the
inheritable arrhythmia syndromes as there is no recognisable
phenotype during cardiological investigation other than
ventricular arrhythmias highly associated with sudden cardiac
death. Until recently, it was impossible to identify presymp-
tomatic family members at risk for fatal events. We uncovered
several genealogically linked families affected by numerous
sudden cardiac deaths over the past centuries, attributed to
familial idiopathic ventricular fibrillation. Notably, ventricular
fibrillation in these families was provoked by very short
coupled monomorphic extrasystoles. We were able to
associate their phenotype of lethal arrhythmic events with a
haplotype harbouring the DPP6 gene. While this gene has not
earlier been related to cardiac arrhythmias, we are now able,
for the first time, to identify and to offer timely treatment to
presymptomatic family members at risk for future fatal events
solely by genetic analysis. Therefore, when there is a familial
history of unexplained sudden cardiac deaths, a link to the
DPP6 gene may be explored as it may enable risk evaluation
of the remaining family members. In addition, when closely
coupled extrasystoles initiate ventricular fibrillation in the
absence of other identifiable causes, a link to the DPP6 gene
should be suspected.
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Introduction
Familial idiopathic ventricular fibrillation (IVF) can be
regarded as the most difficult subset of the inheritable
arrhythmia syndromes [1]. Unlike the other primary arrhyth-
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mia syndromes (e.g. long QT syndrome, catecholaminergic
polymorphic ventricular tachycardias and Brugada syn-
drome), there are no clinical signs of future risk for ventricular
fibrillation (VF) other than a (family) history of (aborted)
sudden cardiac arrest. The expression IVF best acknowl-
edges our current inability to identify a plausible cause or
substrate for the occurrence of VF in these patients who were
previously considered healthy [2]. It is estimated that IVF
accounts for 9000 to 12,500 cases per year in the USA on a
total annual burden of sudden cardiac deaths (SCD) of
approximately 180,000 to 250,000 [3–6]. Because there are
also familial forms of IVF, the risk can be transferred from
parents to children, and subsequently, whole families can be
at risk for VF and SCD. Unfortunately, risk stratification to
determine which of the remaining family members may
develop potentially fatal cardiac arrhythmias has been
impossible due to the lack of clinical abnormalities.
Recently, we have made a breakthrough in several Dutch
families heavily affected by SCD attributed to familial IVF over
the past centuries. We were able to associate their arrhythmic
events with a single haplotype harbouring the DPP6 gene as a
founder effect (i.e. the families are descendants from the same
ancestor) [7]. Because this gene has not earlier been related to
cardiac arrhythmias, we are now able, for the first time, to
identify presymptomatic family members at risk for future
fatal events solely by genetic analysis and treat them
accordingly. Here, we review what we have learned from
these families and discuss the possible mechanisms underly-
ing this form of familial IVF linked to the DPP6 gene.
First clinical contacts with the family
Three separate presentations to our cardiogenetics outpa-
tient clinic finally resulted in the recognition of their
familial connection and ultimately initiated a successful
gene identification study to the culprit genetic abnormality.
Case 1
A 44-year-old woman with an unremarkable medical history
visited our outpatient clinic because of the SCD of her younger
brother and her younger sister. One day, at the age of 31 years,
her previously healthy brother was unexpectedly found dead in
bed, and post-mortem evaluation did not reveal a cause of
death. Several years later, her sister was found dead in bed at
the same age as her deceased brother, and also, she had
previously been considered healthy. Notably, this sister con-
sulted a cardiologist because of palpitations 1 month before her
death. On cardiac examination, she had one non-sustained
ventricular tachycardia on 24-h Holter monitoring, but her
ECG, echocardiography and exercise test were normal. Her
ECG is shown in Fig. 1a. The family history further revealed
that an uncle died unexpectedly at the age of 48 years late in
the evening while he was out to inspect his cattle, and a great
grandfather also died suddenly at a young age. Because of this
impressive family history, the 44-year-old woman underwent
a cardiac examination, which was unremarkable. Her ECG is
shown in Fig. 1b. Because no abnormalities were found, it
Fig. 1 ECGs of two sisters, both of whom experienced sudden
cardiac arrest. a ECG recorded only 1 month before sudden cardiac
death at the age of 31 years while in bed. b ECG recorded only a few
months before resuscitation from IVF at the age of 44 years, while
drinking coffee. ECG a, courtesy of Dr. M.P. van den Berg, University
Medical Center Groningen, the Netherlands
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was discussed that prophylactic treatment was not readily
indicated, but her family members were asked to visit a
cardiologist in a search for an inheritable arrhythmia
syndrome. A few months later, while further cardiac
examinations of her two remaining brothers were carried
out, she suffered from VF while drinking coffee in the
morning. Fortunately, she was successfully resuscitated.
Subsequently, an implantable cardioverter-defibrillator (ICD)
was implanted, which to date has not discharged. However,
only a few months after her resuscitation, her nephew (her
deceased brother’s son) was also resuscitated from VF at the
age of 16 years while climbing stairs. After an unremarkable
complete cardiac examination, he too had an ICD implanted,
and he has received appropriate discharges on several VF
recurrences in the past years.
Case 2
The 69-year-old father of a family contacted our outpatient
clinic because of the SCD of two of his sons. The youngest
son died in his sleep at the age of 32, and the oldest son
died at the age of 37 years while sitting in a car (in the
passenger seat). Both were previously considered healthy.
Post-mortem evaluations did not reveal the cause of these
young deaths. Further family history revealed that the father
had three uncles who had also died unexpectedly in bed.
They were 41, 38 and 28 years old, respectively. As the
father is the link between his sons and his uncles, he was
considered to have transmitted the SCD-related gene defect
although he had been asymptomatic his whole life.
Complete cardiac evaluation of the father and his eight
remaining children (ECG, echocardiography, 24-h Holter
and exercise test) did not reveal abnormalities other than
pulmonary emphysema in the father. Three of his children
chose to have an ICD implanted for primary prevention of
SCD. They all remained free of arrhythmias until now.
However, at the age of 74, the father died from a non-
cardiac cause.
Case 3
A 33-year-old male was admitted to our hospital after his
successful resuscitation. He collapsed after he had just gone
to bed. Besides several unexplained syncopes in the months
preceding the resuscitation, he had an unremarkable
medical history, and complete cardiac examination (ECG,
echocardiography, 24-h Holter and exercise test) revealed
no abnormalities. An ICD was implanted, which appropri-
ately discharged on several VF recurrences during the last
years. Further history taking revealed that two previously
considered healthy nephews of his great grandmother had
died suddenly and unexpectedly, both at the age of 30 years,
one while walking and the other while cycling.
Gene finding study
Classical linkage analyses in familial IVF has previously been
impossible due to the lack of a phenotype which indicates
affected carriers, while those who are affected are only
recognised because of a sudden cardiac arrest which most
often results in death. This scenario often leaves too little
clinical and genetic information to perform successful studies
in a search for the culprit gene. However, genealogical analyses
revealed that the three families mentioned above were in fact
linked many generations before. As we now recognised that
they probably belonged to one family, we were also able to start
an identity-by-descent genome-wide haplotype-sharing analy-
sis. The whole genome of eight family members was
investigated by labelling over 300,000 common genetic
variants (also known as single nucleotide polymorphisms or
SNPs) with the use of Illumina HumanHap BeadChips. This
enabled construction of shared segments (haplotypes) between
the affected family members. As a result, one large haplotype
of 301 contiguous SNPs was found on chromosome 7, which
was highly significantly shared between affected family
members of the three families (Fig. 2). This strongly suggested
that the culprit gene for IVF in this family was located within
this shared region. At this stage, the segment contained four
genes: HTR5A (serotonin receptor in brain), PAX-IP1
(involved in DNA damage response), ACTR3B (expressed in
tumorigenic cell lines) and DPP6 (associated with potassium
channel subunits). Particularly, the last mentioned, DPP6, was
interesting as it encodes for a putative subunit of the ion
channel involved in the transient outward current (Ito) in heart
[8]. However, direct sequencing of all the DPP6 coding exons
in the affected family members did not reveal a mutation.
Instead, a base pair substitution (C>T) was found just outside
the coding region, upstream of one of the initiation codons.
This variant was not documented in 350 controls but could
not be directly marked as pathogenic.
To determine the relevance of DPP6 in familial IVF, we
then screened 42 IVF probands considered unrelated to the
three families of our initial studies for the same variant in
DPP6. In seven families, we indeed identified the same C>T
variant in DPP6. This indicates that they are in fact
descendants from the same ancestors, which was confirmed
by further extensive genealogical research for most families.
Further analyses of the risk haplotype on chromosome 7 in
these additional families allowed us to redefine the shared
region between the affected family members. Subsequently,
the haplotype became smaller and now excluded HTR5A,
PAX-IP1 and ACTR3B. Thus, DPP6 was the only gene in the
remaining shared region. Meanwhile, we identified another
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three probands harbouring this genetic defect, all of them
from families with a high prevalence of SCD.
Although we did not document an exon mutation in
DPP6, we know that regulation of gene expression might
occur outside the coding region. Therefore, we set out to
identify differences in DPP6 expression between affected
family members and controls which could further establish
a role for DPP6 in IVF. Heart biopsies were taken from five
risk haplotype carriers and compared with biopsies from
controls. Indeed, average mRNA expression levels of
DPP6 were increased 22-fold in haplotype carriers as
compared with controls, which indicates the overexpression
of DPP6. Additionally, we excluded changed expression of
the neighbouring genes PAX-1P and ACTR3B.
Further clinical evaluation of DPP6 haplotype carriers
As we had now identified a risk haplotype on chromosome
7 (which contains the DPP6 gene) to be associated with
IVF in these families, we could determine which family
members are at risk for IVF.
Currently, we already have clinical data of 255 family
members of whom 117 carry the risk haplotype. As this is a
founder ‘mutation’, the family members are unevenly
distributed over the country with highest prevalence in the
centre, around the cities of Woerden and Gouda (Fig. 3). Of
course, because of migration, we also identified haplotype
carriers in other parts of the country. This DPP6 founder
mutation now almost reaches the size of another very large
founder mutation, which is associated with cardiac arrests
based on a mutation in the cardiac sodium channel gene
SCN5A [9, 10].
Survival in affected family members is significantly
decreased as can be appreciated from Fig. 4. At the age of
60 years, already 50% of the risk haplotype carriers have
died or experienced a sudden cardiac arrest. As to the
ventricular arrhythmias that affect this family, recordings
show that these are elicited by very short coupled (right)
ventricular extrasystoles (e.g. Fig. 5).
Fig. 2 Shared genetic regions
between affected family
members. SNPs single nucleo-
tide polymorphisms. The
arrow indicates the largest
shared genetic region on
chromosome 7q36
Fig. 3 Distribution of the DPP6
family in the Netherlands. The
founder effect can be appreciat-
ed by the highest prevalence in
the centre of the country. a
Distribution of index patients. b
Distribution of all the family
members. Colours indicate
number of individuals
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Fig. 4 Survival plot showing
mortality or cardiac arrest.
Median survival (50%) for
risk haplotype carriers is
located at 60 years of age
Fig. 5 ECG recording of idiopathic ventricular fibrillation (IVF) in a risk haplotype carrier. The short coupled ventricular extrasystoles from the
right ventricular apex/lower free wall (indicated by asterisks) first result in compensatory pauses and then in IVF requiring external defibrillation
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Treatment
At this moment, we can only determine the risk of IVF in
asymptomatic family members by carrier status of the risk
haplotype on theDPP6 gene. Because this is such a malignant
phenotype, and while we do not have pharmacological
treatment to eradicate the risk of IVF, we now offer ICDs
to risk haplotype carriers between approximately 20 and
50 years. These cutoffs were determined on pedigree analyses
which did not show an increased risk for sudden unexplained
cardiac arrest/death before and after these age boundaries as
compared with the general Dutch population (standardised
mortality ratio) [11]. Although this strategy should prevent
sudden cardiac deaths due to termination of IVF by the ICD,
we are well aware that we also introduce a large burden of
(serious) ICD-related complications to these young persons
[12]. In one of the severely symptomatic patients, quinidine
has been effective in preventing VF recurrence. This closely
follows previous favourable experiences of quinidine in IVF
[13]. In another severely affected patient, the quinidine effect
was only temporary, however. Also, the experience with
ablation therapy in IVF is currently limited [14], but has led
to temporary success in one of the patients.
Mechanisms and further studies
The mechanism by which DPP6 overexpression would result
in IVF without discernable ECG abnormalities is currently
unknown. As mentioned, DPP6 is putatively involved in the
transient outward potassium current Ito in heart [8]. This
current is active in phase 1 of the cardiac action potential.
While DPP6 mRNA seems to be similarly expressed between
epicardium and endocardium, DPP6 overexpression does not
necessarily have to alter the transmural Ito gradient. The latter
may explain the absence of discernable ECG abnormalities.
Our future focus on this family and its members’
vulnerability to IVF has three directions. First, further
clinical studies are deployed to further characterise the
affected versus the non-affected family members by
detailed ECG and imaging studies. When available, we
also plan to perform detailed histological studies on cardiac
tissue. Second, further characterisation of the exact
derangement in the risk haplotype is pursued. And third,
we are working on in vitro studies to recapitulate the effect
of DPP6 derangements on the cardiac action potential to be
able to better understand its arrhythmogenic potential.
Summary
A new arrhythmia gene on chromosome 7q36, DPP6, is
linked to familial IVF and shows a very malignant
phenotype. This phenotype consists of cardiac arrest by
IVF at young age, which is elicited by short coupled
extrasystoles. While this gene has not earlier been related to
cardiac arrhythmias, we are now able, for the first time, to
identify presymptomatic family members at risk for future
fatal events solely by genetic analysis. Affected patients can
be offered preventive treatment accordingly. Therefore,
when there is a family history of unexplained sudden
cardiac deaths, we make the reader aware of this particular
link to the DPP6 gene as it may enable risk stratification of
the remaining family members. In addition, when closely
coupled extrasystoles initiate ventricular fibrillation in the
absence of other identifiable causes, a link to the DPP6
gene should also be suspected.
Acknowledgements We would like to thank the family members for
their cooperation, Sophie van Nes for her efforts in collecting patient
data, all who have worked on this project and all referring physicians
are gratefully acknowledged.
Funding This research is financially supported by ZorgOnderzoek
Nederland (ZonMw), grant number 62000010 and the Netherlands
Heart Foundation (2009B066).
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Viskin S, Belhassen B. Idiopathic ventricular fibrillation. Am
Heart J. 1990;120:661–71.
2. Survivors of out-of-hospital cardiac arrest with apparently normal
heart. Need for definition and standardized clinical evaluation.
Consensus Statement of the Joint Steering Committees of the
Unexplained Cardiac Arrest Registry of Europe and of the
Idiopathic Ventricular Fibrillation Registry of the United States.
Circulation. 1997;95:265–272.
3. Chugh SS, Reinier K, Teodorescu C, et al. Epidemiology of
sudden cardiac death: clinical and research implications. Prog
Cardiovasc Dis. 2008;51:213–28.
4. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation.
1998;98:2334–51.
5. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to
cardiac arrhythmias. N Engl J Med. 2001;345:1473–82.
6. Chugh SS, Jui J, Gunson K, et al. Current burden of sudden
cardiac death: multiple source surveillance versus retrospective
death certificate-based review in a large U.S. community. J Am
Coll Cardiol. 2004;44:1268–75.
7. Alders M, Koopmann TT, Christiaans I, et al. Haplotype-sharing
analysis implicates chromosome 7q36 harboring DPP6 in familial
idiopathic ventricular fibrillation. Am J Hum Genet. 2009;84:468–76.
8. Radicke S, Cotella D, Graf EM, et al. Expression and function of
dipeptidyl-aminopeptidase-like protein 6 as a putative beta-
subunit of human cardiac transient outward current encoded by
Kv4.3. J Physiol. 2005;565:751–6.
9. Postema PG, van den Berg MP, van Tintelen JP, et al. Founder
mutations in the Netherlands. SCN5a 1795insD, the first described
Neth Heart J (2011) 19:290–296 295
arrhythmia overlap syndrome and one of the largest and best described
characterised families worldwide. Neth Heart J. 2009;17:422–8.
10. van den Berg MP, Wilde AA, Viersma JW, et al. Possible
bradycardic mode of death and successful pacemaker treatment in
a large family with features of long QT syndrome type 3 and
Brugada syndrome. J Cardiovasc Electrophysiol. 2001;12:630–6.
11. Sijbrands EJ, Westendorp RG, Defesche JC, et al. Mortality over
two centuries in large pedigree with familial hypercholesterolae-
mia: family tree mortality study. BMJ. 2001;322:1019–23.
12. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of
implantable cardioverter-defibrillator therapy for the prevention of
sudden cardiac death. J Am Coll Cardiol. 2008;52:1111–21.
13. Belhassen B, Glick A, Viskin S. Excellent long-term reproducibility
of the electrophysiologic efficacy of quinidine in patients with
idiopathic ventricular fibrillation and Brugada syndrome. Pacing
Clin Electrophysiol. 2009;32:294–301.
14. Haissaguerre M, Shoda M, Jais P, et al. Mapping and ablation of
idiopathic ventricular fibrillation. Circulation. 2002;106:962–7.
296 Neth Heart J (2011) 19:290–296
